KAREN REAMES: Open Payments
NPI 1962734988 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 61 payments from 15 companies in 2025. Trend: 2023 $1,216 · 2024 $1,292 · 2025 $1,405
Food & beverage: $1,362Education: $44
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 10 | $253 |
| Recor Medical Inc | 8 | $221 |
| Ardelyx, Inc. | 7 | $186 |
| Novartis Pharmaceuticals Corporation | 7 | $171 |
| Calliditas Therapeutics US Inc. | 8 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Vifor Pharma, Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| OPKO Pharmaceuticals, LLC | 2 | $44 |
Products named: Paradise Ultrasound Renal Denervation System, IBSRELA, TARPEYO, Fabhalta, Kerendia, JYNARQUE, Vanrafia, Veltassa.
Industry payments across TN — which companies pay providers there.
